Back to Search Start Over

Lenabasum improved skin symptoms, but future is uncertain

Authors :
Kilgore, Christine
Source :
Dermatology News. June, 2022, Vol. 53 Issue 6, p37, 2 p.
Publication Year :
2022

Abstract

AN INVESTIGATIVE SYNTHETIC cannabinoid receptor type 2 (CB2) agonist, lenabasum, was associated with greater improvements than placebo in patients with skin-predominant dermatomyositis--some of it statistically significant--in a phase 2, double-blind, [...]

Subjects

Subjects :
Medical research
Medicine, Experimental
Skin -- Research
Health
Health care industry

Details

Language :
English
ISSN :
23767006
Volume :
53
Issue :
6
Database :
Gale General OneFile
Journal :
Dermatology News
Publication Type :
Periodical
Accession number :
edsgcl.715558799

Tools

Authors Abstract Subjects Details